How can the industry achieve excellence when its training programs are geared to meeting minimum regulatory guidelines?
BioPharm International
eBooks Volume 28, Issue 14
Training remains one of the most effective ways to build up the skills of employees within any organization. When it comes to training in the pharmaceutical industry, however, practices are a bit less robust and results can be more variable and disappointing. Read this article and other articles in
BioPharm International
's 2015
The Future of BioprocessingeBook.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.